Predominantly Antibody Deficiency

Gene: DNMT3B

Green List (high evidence)

DNMT3B (DNA methyltransferase 3 beta)
EnsemblGeneIds (GRCh38): ENSG00000088305
EnsemblGeneIds (GRCh37): ENSG00000088305
OMIM: 602900, Gene2Phenotype
DNMT3B is in 14 panels

1 review

Danielle Ariti (University of Melbourne)

Green List (high evidence)

Well-established disease-gene association; more than 20 unrelated individuals; three mouse models

Homozygous and compound heterozygous missense, nonsense, splice-site (leading to 3aa insertion) result in LOF disease mechanism.

Individuals typically presented with immunodeficiencies (decreased immunoglobulin production, low T/B/NK cells), centric instability, facial anomalies and recurrent respiratory infections; however, severity varies.
Created: 27 Jul 2021, 6:40 a.m. | Last Modified: 27 Jul 2021, 6:40 a.m.
Panel Version: 0.68

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
mmunodeficiency-centromeric instability-facial anomalies syndrome 1 MIM# 242860; facial dysmorphic features; flat nasal bridge; developmental delay; macroglossia; bacterial/opportunistic infections (recurrent); malabsorption; cytopaenia; malignancies; multiradial configurations of chromosomes 1, 9, 16; Hypogammaglobulinaemia; agammaglobulinaemia; variable antibody deficiency; decreased immunoglobulin production; low T/B/NK cells

Publications

History Filter Activity

11 Nov 2022, Gel status: 3

Added Tag

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Tag treatable tag was added to gene: DNMT3B.

17 Nov 2019, Gel status: 3

Created, Added New Source, Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

gene: DNMT3B was added gene: DNMT3B was added to Predominantly antibody deficiency_MelbourneGenomics_AustralianGenomics_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services,Melbourne Genomics Health Alliance Immunology Flagship Mode of inheritance for gene: DNMT3B was set to Unknown